{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:45:18Z","timestamp":1773827118415,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pep.2024.106620","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T02:05:17Z","timestamp":1730772317000},"page":"106620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Nature of recombinant human serum amyloid A1 in Escherichia coli and its preferable approach for purification"],"prefix":"10.1016","volume":"227","author":[{"given":"Saira","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-2790","authenticated-orcid":false,"given":"Qurratulann Afza","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisar Ahmad","family":"Shakir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabahat","family":"Gulzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naseema","family":"Azim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2024.106620_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129409148635","article-title":"Serum amyloid A (SAA): biochemistry, genetics and the pathogenesis of AA amyloidosis","volume":"1","author":"Husby","year":"1994","journal-title":"Amyloid"},{"key":"10.1016\/j.pep.2024.106620_bib2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.pep.2024.106620_bib3","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.cell.2012.02.022","article-title":"The amyloid state of proteins in human diseases","volume":"148","author":"Eisenberg","year":"2012","journal-title":"Cell."},{"key":"10.1016\/j.pep.2024.106620_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016 nomenclature guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"key":"10.1016\/j.pep.2024.106620_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0140-6736(00)05252-1","article-title":"Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein","volume":"358","author":"Gillmore","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.pep.2024.106620_bib6","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.pep.2024.106620_bib7","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pep.2024.106620_bib8","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/13506120500223084","article-title":"From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature","volume":"12","author":"Wang","year":"2005","journal-title":"Amyloid"},{"key":"10.1016\/j.pep.2024.106620_bib9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.chemphyslip.2016.11.004","article-title":"Effect of lipid environment on amyloid fibril formation of human serum amyloid A","volume":"202","author":"Tanaka","year":"2017","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.pep.2024.106620_bib10","doi-asserted-by":"crossref","first-page":"10708","DOI":"10.1021\/acs.jpcb.0c08280","article-title":"Stability of human serum amyloid A fibrils","volume":"124","author":"Wang","year":"2020","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.pep.2024.106620_bib11","doi-asserted-by":"crossref","first-page":"12186","DOI":"10.1021\/acsomega.2c00566","article-title":"Interconversion between Serum Amyloid A native and fibril conformations","volume":"7","author":"Yasar","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.pep.2024.106620_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/cs0680233","article-title":"Comparative study of serum amyloid A protein and C-reactive protein in disease","volume":"68","author":"Maury","year":"1985","journal-title":"Clin. Sci. (Lond)."},{"key":"10.1016\/j.pep.2024.106620_bib13","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.pep.2024.106620_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13506120500106941","article-title":"Serum amyloid A in geese; cloning and expression of recombinant protein","volume":"12","author":"Kov\u00e1cs","year":"2005","journal-title":"Amyloid"},{"key":"10.1016\/j.pep.2024.106620_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0925-4439(94)90044-2","article-title":"Fibril formation from recombinant human serum amyloid A","volume":"1226","author":"Yamada","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pep.2024.106620_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1134\/S0006297916030019","article-title":"Overview of fusion tags for recombinant proteins","volume":"81","author":"Kosobokova","year":"2016","journal-title":"Biochem. (Mosc.)"},{"key":"10.1016\/j.pep.2024.106620_bib17","article-title":"Influence of C-terminal truncation of murine Serum amyloid A on fibril structure","volume":"6170","author":"Rennegarbe","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pep.2024.106620_bib18","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.bbapap.2012.09.004","article-title":"Studies on the regioselectivity and kinetics of the action of trypsin on proinsulin and its derivatives using mass spectrometry","volume":"1834","author":"Gardner","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pep.2024.106620_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103117","article-title":"Mechanistic studies on Pyrobaculum calidifontis porphobilinogen synthase (5-aminolevulinic acid dehydratase)","volume":"91","author":"Azim","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.pep.2024.106620_bib20","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00253-018-9509-0","article-title":"Ethanol effects on the overexpression of heterologous catalase in Escherichia coli BL21 (DE3)","volume":"103","author":"Zheng","year":"2019","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.pep.2024.106620_bib21","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.procbio.2021.11.029","article-title":"Ethanol as additive enhances expression of Ranibizumab in Escherichia coli: impact on cellular physiology and transcriptome","volume":"112","author":"Priyanka","year":"2022","journal-title":"Process Biochem."},{"key":"10.1016\/j.pep.2024.106620_bib22","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0076-6879(55)01014-8","article-title":"[10] Protein fractionation on the basis of solubility in aqueous solutions of salts and organic solvents","author":"Green","year":"1955"},{"key":"10.1016\/j.pep.2024.106620_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/nprot.2006.4","article-title":"Tricine-SDS-PAGE","volume":"1","author":"Sch\u00e4gger","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pep.2024.106620_bib24","series-title":"Protein Purification: Principles and Practice","author":"Scopes","year":"1993"},{"key":"10.1016\/j.pep.2024.106620_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0022-1759(96)00149-4","article-title":"Generation of soluble recombinant human acute phase serum amyloid A2 (A-SAA2) protein and its use in development of an A-SAA specific ELISA","volume":"198","author":"McCormack","year":"1996","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.pep.2024.106620_bib26","article-title":"Opportunities and challenges of the tag-assisted protein purification techniques: applications in the pharmaceutical industry","volume":"45","author":"Gomari","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.pep.2024.106620_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1292\/jvms.61.915","article-title":"Expression of recombinant feline serum amyloid A (SAA) protein","volume":"61","author":"Ohno","year":"1999","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.pep.2024.106620_bib28","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1042\/bj3181041","article-title":"Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis","volume":"318","author":"Patel","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.pep.2024.106620_bib29","doi-asserted-by":"crossref","first-page":"20606","DOI":"10.1016\/S0021-9258(20)80768-6","article-title":"Structural prerequisites for serum amyloid A fibril formation","volume":"268","author":"de Beer","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pep.2024.106620_bib30","doi-asserted-by":"crossref","first-page":"6.14.1","DOI":"10.1002\/cpps.29","article-title":"N-terminal methionine processing","volume":"88","author":"Wingfield","year":"2017","journal-title":"Curr. Protoc. Protein. Sci."},{"key":"10.1016\/j.pep.2024.106620_bib31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bies.950030108","article-title":"Methionine or not methionine at the beginning of a protein","volume":"3","author":"Sherman","year":"1985","journal-title":"Bioessays"},{"key":"10.1016\/j.pep.2024.106620_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","article-title":"Protein misfolding, amyloid formation, and human Disease: a summary of progress over the last decade","volume":"86","author":"Chiti","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.pep.2024.106620_bib33","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.15252\/embr.201643411","article-title":"Cellular mechanism of fibril formation from serum amyloid A1 protein","volume":"18","author":"Claus","year":"2017","journal-title":"EMBO Rep."},{"key":"10.1016\/j.pep.2024.106620_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064974","article-title":"Characterization of the oligomerization and aggregation of human Serum Amyloid A","volume":"8","author":"Patke","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pep.2024.106620_bib35","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1002\/vms3.522","article-title":"Elevated temperatures accelerate the formation of toxic amyloid fibrils of hen egg-white lysozyme","volume":"7","author":"Feng","year":"2021","journal-title":"Vet. Med. Sci."}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104659282400192X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104659282400192X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T09:08:29Z","timestamp":1735376909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104659282400192X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"alternative-id":["S104659282400192X"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2024.106620","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nature of recombinant human serum amyloid A1 in Escherichia coli and its preferable approach for purification","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2024.106620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106620"}}